More inflammatory mediators, including cytokines, chemokines, IL-5, and acidity levels, can be measured in the exhaled breath condensate and serve as metabolomic biomarkers of asthma exacerbation in the future [36,96]. This evidence concerns the gene IL5 and asthma.